61 – 70 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Increased autoantibodies to SOX13 in Swedish patients with type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes.
(
- Contribution to journal › Letter
- 2001
-
Mark
Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage
(
- Contribution to journal › Article
-
Mark
Beta cell function in autoimmune diabetes in young adults
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - A nationwide study
(
- Contribution to journal › Article
-
Mark
The length of the CTLA-4 microsatellite (AT)(N)-repeat affects the risk for type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Prognostic factors for the course of β cell function in autoimmune diabetes
(
- Contribution to journal › Article
-
Mark
Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies
(
- Contribution to journal › Article
-
Mark
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes
(
- Contribution to journal › Article
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article